PIUG 2019 BIOTECHNOLOGY CONFERENCE - BizInt Solutions PIUG Biotech Meeting Book Final.pdf · PIUG...

February 19 – 21, 2019 Kimpton Marlowe Hotel Cambridge, MA

PIUG 2019 BIOTECHNOLOGY CONFERENCE

Patent Information Users Group, Inc.

Meeting Book prepared by BizInt Solutions Inc., a proud sponsor of the 2019 PIUG Biotechnology Conference

W O R K S H O P S : T H U R S D A Y , F E B R U A R Y 2 1 , 2 0 1 9 - S E E P A G E 2 8

February 19-21, 2019 Kimpton Marlowe Hotel Cambridge, MAPIUG 2019 BIOTECHNOLOGY CONFERENCE

7:30 am – 8:00 am Registration and Exhibits

8:00 am – 8:15 am Welcoming Remarks & Meeting Logistics

8:15 am – 9:15 am Keynote Address: Post-Issuance Options for Challenging U.S. Patents Lisa L. Mueller, Casimir Jones, S.C.

9:15 am – 9:45 am Using CPC in Biotechnology Areas Sue Liu, USPTO

9:45 am – 10:00 am Product Reviews – BizInt, Aptean GenomeQuest

10:00 am – 10:30 am Break & Vendor Exhibits

10:30 am – 11:00 am The Evolving Patent Landscape of Therapeutic Manipulation of the Human Microbiome Larry Mulcahy, Clarivate Analytics

11:00 am – 11:30 am Patent Family Differences across Databases and How It Impacts Search and Report Alison Taylor Abbott Laboratories

11:30 am – 12:00 pm WIPO Standard ST.26 in a Nutshell Sue Wolski,USPTO

12:00 pm – 1:30 pm Lunch & Vendor Exhibits

1:30 pm – 2:30 pm Panel Discussion—Sequence Searching: Past, Present, and Future Yugong Cheng, Elanco; Cynthia Gallagher, Pfizer; Lisa L. Mueller, Casimir Jones; Victoria Smith, Novartis; Monica Wu, Merck

2:30 pm – 3:00 pm Product Reviews: CAS, Minesoft, Questel, STN

3:00 pm – 3:30 pm Break & Vendor Exhibits

3:30 pm – 4:00 pm Bringing Patent Information to the Engineering Community Christine M. Reilley, ASME

4:00 pm – 4:30 pm The Growth of the Medical Devices and Its Impact on the USPTO Jackie Cheng, USPTO

4:30 pm Closing Remarks

5:30 pm Networking Dinner (registration required)

W O R K S H O P S : T U E S D A Y , F E B R U A R Y 1 9 , 2 0 1 9 - S E E P A G E 2 8

C O N F E R E N C E : W E D N E S D A Y , F E B R U A R Y 2 0 , 2 0 1 9 ( S E R R A N O A / B / C )

2019 BIOTECHNOLOGY CONFERENCEFebruary 19–21, 2019 Kimpton Marlowe Hotel Cambridge, Massachusetts

T A B L E O F C O N T E N T S

Message from the Chair ..............................................................2

Thank You to Sponsors ...............................................................3

Morning Speakers .........................................................................4

Afternoon Speakers .................................................................. 18

Attendees by Name .................................................................. 26

Attendees by Company ........................................................... 27

Workshops ................................................................................... 28

#PIUG19BIO

Evaluate the conference at: https://www.surveygizmo.com/s3/4792964/PIUG-2019-Biotech

PIUG 2019 Biotechnology Conference Cambridge, Massachusetts

On behalf of the PIUG Board of Directors, I want to welcome you to the PIUG 2019 Biotechnology Conference. The organizing committee has worked hard to put together an outstanding program for you.

planning committee:Board Liaison : Shelley Pavlek

Evaluation : Christine Geluk

Exhibitor Liaison: Qin Meng

Hospitality / Travel : Qin Meng

Meeting Book : Diane Webb, Alison Taylor

Networking : Richard Williams

On-Site Logistics: Qin Meng

Planning : Qin Meng, Alison Taylor

Program: Greg Roland, Qin Meng, Barbara Miller, Leah Sandvoss, Ellen Sherin

Publicity : Ellen Sherin

Registration : Donna Fisher

Social Media : Christine Geluk

Web Pages: Richard Williams

Wiki: Thomas Wolff

Workshops: Elyse Turner, Monica Weiss-Nolen, Jordan Bell, Dillon Cawley, Alison Taylor

I hope you learn at least one new thing today and make one new contact. I find networking to be one of the most profitable aspects of PIUG.

Thank you to all the volunteers who make PIUG and the Biotechnology Conference work. Thank you to all the sponsors of the conference. Please stop by their booths and hear about their products and let them know how much we appreciate their support.

Welcome to Cambridge!

Martha Yates, PIUG Chair 2018-2020

Message from the Chair

2 PIUG 2019 Biotechnology Conference Cambridge, Massachusetts

gratefully acknowledges the generous support

provided by our sponsors. The meeting would not exist

without their support!

Gold SponsorsAPTEAN GENOMEQUEST

Aptean GenomeQuest enables companies to search worldwide patent literature for

biological sequences. Its database, GQ-Pat, is the largest repository of sequences cited

in patents. IP professionals and law firms use GenomeQuest to perform freedom to

operate, patentability, validity, and prior art searches. GenomeQuest serves 18 of the

top 20 pharmaceutical companies and all five top agrochemical companies, with a

customer base of nearly 200 leading life science and biotechnology organizations.

BIZINT SOLUTIONS

BizInt Smart Charts software helps information analysts create, customize and

distribute competitive intelligence reports and visualizations from drug pipeline,

clinical trial, patent and gene sequence databases. The BizInt Smart Charts product

family is used by pharmaceutical, biotech, chemical and device/diagnostics companies

worldwide to support product life cycle planning and portfolio management.

Bronze SponsorsCAS

MinesoftQuestel

STN

3PIUG 2019 Biotechnology Conference Cambridge, Massachusetts

Post-Issuance Options for Challenging U.S. PatentsLisa L. Mueller, Casimir Jones, S.C.

8:15 – 9:15 am

ABSTRACT

This session will review the various post-issuance options available at the U.S. Patent and Trademark

Office for challenging the validity of a patent, such as inter partes and post grant reviews as well as ex

parte reexamination. Specifically, this session will discuss the requirements for each of these post-

issuance options, the similarities and differences between each, the requisite filing requirements,

the timelines for submission and response, how each of these post-issuance options has affected

biotechnology and pharmaceutical related patents and the important role that searchers play

in helping attorneys prepare the documents needed in support of a post-issuance options or in

defense thereof.

BIOGRAPHY

For over twenty-five years, Lisa has provided strategic counsel on complex patent issues to clients

in the pharmaceutical, biopharmaceutical, biotechnology and chemistry sectors. She brings an

in-depth knowledge and extensive experience to her work advising clients on the global patent

protection, freedom to operate and validity of blockbuster drugs they aim to produce and distribute.

Since 2001, Lisa has worked closely with in-house legal departments of global pharmaceutical firms

regarding their patent development and enforcement strategies. In this partnership, she provides

training to new in-house counsel and meets with scientists and other business development

colleagues to anticipate and resolve a wide array of problems including navigation of U.S. Food and

Drug Administration approval.

A thought leader on pharmaceutical and biopharmaceutical patent law, Lisa speaks frequently to

legal and industry groups, and publishes widely. She was the author of an award-winning blog,

BRIC Wall, which provides unique insights on patent law developments in the life sciences industry

in Brazil, Russia, India and China. Lisa is currently the author of the blog, BRICS & Beyond (https://

bricsandbeyond.blog/) which provides unique insights on patent law developments in the life

sciences industry not only in Brazil, Russia, India and China but in other countries outside of the

United States.

M O R N I N G S P E A K E R S


Post-Issuance Options for Challenging U.S. Patents Lisa L. Mueller, Casimir Jones, S.C.


Using CPC in Biotechnology AreasSue Liu, USPTO

9:15 – 9:45 am

ABSTRACT

Cooperative Patent Classification (CPC) is the current classification system used by USPTO, and it is

jointly maintained by USPTO and EPO (European Patent Office). In this presentation, a brief overview

of the CPC areas that cover biotechnology and chemical subject matters and how to classify using

CPC will be provided. Examples of searching using CPC including C-set searching will be discussed.

BIOGRAPHY

Sue Liu is currently a Supervisory Patent Examiner in the biotechnology area at the United States

Patent and Trademark Office (USPTO). Her Art Unit examines applications in pharmaceutical

formulations, biocides, cosmetics, and related areas. She joined USPTO as a patent examiner in the

Combinatorial Chemistry Art Unit. Before joining the USPTO, Sue was a postdoctoral fellow at FDA.

Sue studied transcriptional regulation in vaccinia virus for her Ph.D. thesis and graduated from the

Department of Biochemistry, Purdue University. She obtained her BS degrees in Chemistry and

Psychology from Arizona State University (ASU) and graduated from ASU’s Honors College.



Using CPC in Biotechnology Areas Sue Liu, USPTO


Product Reviews

9:45 – 10:00 am (Gold sponsors):

BizInt Aptean GenomeQuest

2:30 – 3:00 pm (Bronze sponsors):

CAS Minesoft Questel STN


Product Reviews


The Evolving Patent Landscape of Therapeutic Manipulation of the Human MicrobiomeLarry Mulcahy, Clarivate Analytics

10:30 – 11:00 am

ABSTRACT

The earliest stage companies focused on human microbiome therapies have progressed into late

stage clinical trials. I will review early approaches used to identify human microbiome focused

companies and recommended updates for searching the space. I will build off of my 2016

presentation at the 2016 PIUG Biotech meeting with updates on language, classes, companies to

watch. Additionally, I will present some representative examples of different patented technologies

in the space that have progressed into the clinic.

BIOGRAPHY

Larry Mulcahy is a Solution Consultant at Clarivate Analytics where his primary responsibility is to

train and consult with users on Derwent based databases and solutions, specializing in research

and analytics of patent and non-patent literature. With his background in education, Larry has

conducted patent search and patent landscaping courses as part of two master’s programs.

Larry has experience in several life sciences fields as a graduate student, postdoctoral fellow, and

applications scientist. Larry received his Ph.D. from Brown University in Molecular & Cellular Biology

and Biochemistry. He lives with his family in the suburbs of Boston, MA.



The Evolving Patent Landscape of Therapeutic Manipulation of the Human Microbiome Larry Mulcahy, Clarivate Analytics



Patent Family Differences across Databases and How It Impacts Search and ReportAlison Taylor, Abbott Laboratories

11:00 – 11:30 am

ABSTRACT

As a professional patent searcher the use of multiple patent information databases is essential.

There are many advantages to using more than one resource when researching life science-related,

technical inventions. However, each resource may group and present the data in slightly different

ways, including the way in which patents are grouped into families. It is important to understand

these differences and to make the necessary adjustments to your search strategies in order to run a

complete search.

This talk will review the differences between major patent information resources and give examples

of features to consider for inclusion into your search report.

BIOGRAPHY

Alison Taylor is a patent searcher in the Legal Department at Abbott Labs., Abbott Park, Illinois, USA.

She has a Bachelor’s in Biochemistry from the University of Surrey, U.K. and a PhD in Biochemistry /

Molecular Biology from King’s College London, U.K. She was a researcher in the Molecular Biology

Labs at Abbott for five years at the start of her career but has been a searcher since 1995, after

leaving the lab. and working in the library at the Nutrasweet Company, part of Monsanto. She

later moved on to the pharmaceutical research library of Monsanto, which became Pharmacia,

and following closure of this site in 2004, joined Threshold Information, a small private information

search company. In 2009 she joined Abbott Labs. as a patent searcher with a focus on biological /

life sciences and currently supports the Legal division on searches related to diagnostics, biologic

pharmaceuticals and competitive intelligence.


Patent Family Differences across Databases and How It Impacts Search and Report Alison Taylor, Abbott Laboratories


WIPO Standard ST.26 in a NutshellSue Wolski, USPTO

11:30 am – 12:00 pm

ABSTRACT

Current WIPO Standard ST.25 for the presentation of sequence listings in patent applications

became effective in 1998 and has not been substantively revised since then. The Committee on

WIPO Standards (CWS) established a Sequence Listing Task Force in 2010 to revise the standard

and create new WIPO Standard ST.26. This presentation will provide a brief overview, including the

benefits of the new standard, the major differences between ST.25 and ST.26, transition provisions,

and the various components of the standard.

BIOGRAPHY

Susan Wolski has been a PCT Special Programs Examiner in International Patent Legal

Administration (formerly Office of PCT Legal Administration) at the USPTO since 1998. She teaches

classes to patent examiners on international and national stage applications filed under the Patent

Cooperation Treaty, gives seminars on the Treaty and the filing of biological sequences to various

groups outside the USPTO, and participates in a number of special projects, including modification

of the standard for the filing of biological sequences in patent applications. Sue began her tenure

at the USPTO in 1990 as a patent examiner in biotechnology (immunoassays), completed her law

degree at George Washington University during that time, and is now member of the Virginia

Bar. She has earned two Department of Commerce Gold Medal Awards and four Bronze Medal

Awards for her work, as well as an Exceptional Career Award. Prior to joining the USPTO, she earned

a Bachelor of Science degree in Microbiology and a Master’s Degree in Immunology from the

University of Maryland (College Park). She has also worked in biological research at the University of

Maryland, the American Type Culture Collection, and the Uniformed Services University, and in the

sales of scientific instrumentation for Beckman Instruments.



WIPO Standard ST.26 in a Nutshell Sue Wolski, USPTO


Panel Discussion: Sequence Searching: Past, Present and FutureYugong Cheng, Elanco; Cynthia Gallagher, Pfizer, Lisa L. Mueller Casimir Jones; Victoria Smith, Novartis; Monica Wu, Merck

1:30 – 2:30 pm

BIOGRAPHIES

Yugong Cheng, PhD, is currently a patent research consultant at the Elanco Animal Health (a spin-off

from Eli Lilly and Company) in Greenfield, IN, focusing on patent searches and analysis for biotech

and biomedicine. Prior to joining Lilly in 2007, he was a computational biologist at Molecular Kinetics

and a research associate at Indiana University Purdue University at Indianapolis. He has a PhD in

Biochemistry and a MS in Computer Science from University Vermont, Burlington, VT, and a BS in

Chemistry from Beijing University, Beijing, China.

Cynthia Gallagher, PhD, Manager, Patent Searching & Information, Pfizer Legal Division, has been part

of Patent Searching & Information (formerly known as GLIST) in the Intellectual Property department

at Pfizer since 2005. When she started at Pfizer, she provided search support for chemistry related

patent search requests and now provides search support for biotechnology related patent search

requests. She started her career as an information Scientist as a chemistry searcher at Merck in 2004.

She has a PhD in Chemistry from the University of Vermont, an MA in Biology from Lehman College,

CUNY and a BA in Chemistry from the College of Holy Cross.

Victoria Smith, PhD, Patent Analyst I, Novartis Institutes for BioMedical Research, received her Ph.D. in

Biological Sciences from the University of Notre Dame in 2016. While at the university, she worked

in the areas of immunology, cancer biology, and infectious diseases. During her time in the lab,

Victoria began to transition her career interests to intellectual property and, in 2015, enrolled in a

Master of Science in Patent Law program at the University of Notre Dame. Through participation

in this program and a subsequent internship at the University of Notre Dame Office of Technology

Transfer, she was taught the foundations of patent law, application drafting, and patent searching

and analysis. Victoria joined Novartis in October 2017 as a patent analyst for the Research &

Development IP team at NIBR.

Lisa L. Mueller, Casimir Jones, S.C. See page 4.

Monica Wu, Patent Information Specialist, Merck, is currently a patent information specialist at

Merck company in Rahway, NJ and provides patent information services to all bio-related IP areas.

She started her career as a patent searcher at DuPont in 2010 and supported Biotechnology and

Agriculture business units. She has a Master in Biophysics from University of Virginia and a BS in

Medicinal Chemistry from Beijing Medical University.

A F T E R N O O N S P E A K E R S


Panel Discussion: Sequence Searching: Past, Present and Future Yugong Cheng, Elanco; Cynthia Gallagher, Pfizer, Lisa L. Mueller Casimir Jones; Victoria Smith, Novartis; Monica Wu, Merck



Bringing Patent Information to the Engineering CommunityChristine M. Reilley, ASME

3:30 – 4:00pm

ABSTRACT

The American Society of Mechanical Engineers (ASME) recently launched an initiative to support

engineers in the bioengineering and medical devices industries. As part of this initiative, known as

the Alliance of Advanced Biomedical Engineering (https://aabme.asme.org), we identified the top

challenges expressed by our stakeholders, which include:

» Understanding more about IP and patent

» Overcoming difficulties commercializing products

» Navigating the regulatory landscape

» Connecting with experts beyond the engineering community

We are looking to connect the ASME/AABME community with PIUG, as we believe such a connection

can enable exchange of information and instruction that can ultimately solve these challenges.

ASME, a not-for-profit professional society and standards developing organization, was founded in 1880

to advance a mission of improving the quality of human life. The mission continues to this day, serving

130,000 members worldwide.

BIOGRAPHY

Christine Reilley is business development director of Healthcare for the American Society of Mechanical

Engineers (ASME), based in New York City. As director, she leads the ASME Alliance of Advanced

Biomedical Engineering (AABME), which focuses on creating and growing the Society’s portfolio of

programs, products, and services in this area.

Christine previously served as program manager in the ASME Emerging Technologies unit, developing

content and conferences in areas focusing on bioengineering, nanotechnology, thermofluids, and

materials. Previously, she spent more than 10 years in ASME Codes and Standards Publishing as an

editor, overseeing the production of codes.

She earned an MS in Biomedical Engineering with a concentration in Tissue Engineering and

Biomaterials from New Jersey Institute of Technology (NJIT). She received a BA in Journalism and Mass

Media with a minor in Biological Sciences from Rutgers University, Douglass College.


Bringing Patent Information to the Engineering Community Christine M. Reilley, ASME



The Growth of the Medical Devices and Its Impact on the USPTOJackie Cheng, USPTO

4:00 – 4:30pm

ABSTRACT

The medical device industry has grown quickly over the years, the devices becoming more

sophisticated and encompassing technologies from different areas. In this presentation a brief

discussion of how this growth has impacted examiners at the USPTO and how they search.

BIOGRAPHY

Jackie Cheng is currently a Supervisory Patent Examiner in the biomedical area at the United States

Patent and Trademark Office (USPTO). Her Art Unit examines applications in a variety of medical

diagnostics including cardiovascular monitoring, respiratory monitoring, and analyte sensing. She

started her career at the USPTO as a Patent Examiner examining applications in the field of medical

imaging. She obtained her dual degree BS in Electrical and Computer Engineering and in Biomedical

Engineering from Carnegie Mellon University.


The Growth of the Medical Devices and Its Impact on the USPTO Jackie Cheng, USPTO


Partner with CAS to keep your IP strategy ahead of the curve

Stay ahead,whatever the challenge!

Patent information can be challenging.Minesoft provides intelligent & reliable

solutions to help you take the lead.PatBase, now hosting 60 full text collections

NEW PatDocs, the ideal solution to streamlinethe workload of IP professionals

Chemical Explorer, extract essential chemicalinformation from the full text of patents

Visit the Minesoft stand, attend the Minesoftworkshop (February 19th - 11AM) or go towww.minesoft.com for more information.

PIUG bio advert.qxp_Layout 1 15/01/2019 15:58 Page 1


Orbit BioSequenceSequence searching now available in Questel’s Orbit Intelligence

go.questel.com/biosequence

The majority of STN usage happens on STNext. What are you waiting for?

Login to STNext today at next.stn.org

Biosequence searching is now available on


Ahmad, Zahoor ......................................Abdul Wali Khan UniversityAkuamoah, Akua ...................................GQ Life SciencesAllen, Stephen .........................................Aptean GenomeQuestAvitto, Anna .............................................MinesoftArbisman, Chloe .................................... IQVIABaldwin, Christopher ...........................PatentSight GmbHBarrett, Dianah ........................................PfizerBayada, Denis ..........................................QuestelBrooks, Michelle .....................................Harbor Consulting IP ServicesBrown, Jim ................................................FIZ KarlsruheBurnett, Ned ............................................Saint GobainCawley, Dillon ..........................................AbbottCheng, Yugong ......................................Elanco Animal HealthD’Anjou, Hélène .....................................Aligo InnovationEggerichs, Gin-Yun ...............................AbbVieFisher, Donna ...........................................Follansbee, Tracy ...................................ElsevierGallagher, Cynthia .................................PfizerGibson, Kathy ..........................................CASGieber, Lisa ............................................... IAVIHower, Mark .............................................Fairview Research/IFI CLAIMSJacobs, Andrea........................................CASJiang, Ning ................................................PfizerJohnson, Brett .........................................SercoJones, Jackie ............................................Harbor Consulting IP ServicesKandi-Masakidi, Amandine ..............QuestelKim, Gene..................................................Triplet TherapeuticsLewis-Gallagher, Jennifer ...................Digital ScienceList, Jane ....................................................Extract InformationLiu, Sue .......................................................USPTOMarman, Tom ..........................................PfizerMendelson, Seth ....................................EisaiMeng, Qin .................................................Fairview Research/IFI CLAIMSMiller, Susan .............................................CASMueller, Lisa..............................................Casimir JonesMulcahy, Larry .........................................Clarivate AnalyticsReilley, Christine .....................................ASMEResnick, Jason .........................................MinesoftRix, Tara ......................................................Harbor Consulting IP ServicesRobins, Suzanne ....................................Patent Information ServicesRoland, Greg ............................................NovartisShanker, Sumana ...................................Shire PharmaceuticalsSherin, Ellen ..............................................GQ Life SciencesSmith, Victoria .........................................NovartisStewart, Catherine ................................AbbVieSweet, Brian .............................................CAS

Talwar, Bela ...............................................H K Acharya & CompanyTan, John ...................................................Taylor, Alison ............................................AbbottTurner, Elyse .............................................Walczak, Rob ...........................................CASWebb, Diane ............................................BizInt SolutionsWillmore, John ........................................BizInt SolutionsWolski, Susan ...........................................USPTOWu, Man ....................................................Merck & Co.Young, Jessica .........................................Darts-ip

A T T E N D E E S B Y N A M E


Abbott ........................................................Dillon CawleyAbbott ........................................................Alison TaylorAbbVie ........................................................Gin-Yun EggerichsAbbVie ........................................................Catherine StewartAbdul Wali Khan University ..............Zahoor AhmadAligo Innovation ....................................Hélène D’AnjouAptean GenomeQuest .......................Stephen AllenASME ...........................................................Christine ReilleyBizInt Solutions .......................................Diane WebbBizInt Solutions .......................................John WillmoreCAS ...............................................................Kathy GibsonCAS ...............................................................Andrea JacobsCAS ...............................................................Susan MillerCAS ...............................................................Brian SweetCAS ...............................................................Rob WalczakCasimir Jones ..........................................Lisa MuellerClarivate Analytics .................................Larry MulcahyDarts-ip ......................................................Jessica YoungDigital Science ........................................Jennifer Lewis-GallagherEisai ..............................................................Seth MendelsonElanco Animal Health ..........................Yugong ChengElsevier ........................................................Tracy FollansbeeExtract Information ..............................Jane ListFairview Research/IFI CLAIMS .........Mark HowerFairview Research/IFI CLAIMS .........Qin MengFIZ Karlsruhe ............................................Jim BrownGQ Life Sciences ....................................Akua AkuamoahGQ Life Sciences ....................................Ellen SherinH K ACHARYA & COMPANY ..............BELA TALWARHarbor Consulting IP Services .........Michelle BrooksHarbor Consulting IP Services .........Jackie JonesHarbor Consulting IP Services .........Tara RixIAVI................................................................Lisa GieberIQVIA ............................................................Chloe ArbismanMerck & Co. ..............................................Man WuMinesoft.....................................................Anna AvittoMinesoft.....................................................Jason ResnickNovartis ......................................................Greg RolandNovartis ......................................................Victoria SmithPatent Information Services .............Suzanne RobinsPatentSight GmbH ...............................Christopher BaldwinPfizer ............................................................Dianah BarrettPfizer ............................................................Cynthia GallagherPfizer ............................................................Ning JiangPfizer ............................................................Tom MarmanQuestel .......................................................Denis Bayada

Questel .......................................................Amandine Kandi-MasakidiSaint Gobain ............................................Ned BurnettSerco ............................................................Brett JohnsonShire Pharmaceuticals .........................Sumana ShankerTriplet Therapeutics .............................Gene KimUSPTO .........................................................Sue LiuUSPTO .........................................................Susan Wolski

A T T E N D E E S B Y C O M P A N Y


Tuesday, 19 February Workshop

8:30 am – 10:30 am STN: Sequence Searching in STNext

11:00 am – 12:00 pm Minesoft: How To Take Advantage of New Features in PatBase, an Exploration of PatDocs, and What To Expect Next from Minesoft

1:00 pm – 2:00 pm BizInt Solutions: Creating IP Reports Integrating Sequence and Family Data with BizInt Smart Charts for Patents

2:15 pm – 3:15 pm Aptean GenomeQuest: Searching for Variant Sequences with Pinpoint Accuracy

3:30 pm – 4:30 pm Questel: Orbit BioSequence: Combining Sequence Searching with Motif Finding, Keywords in Fulltext, and Chemistry

Thursday, 21 February Workshop

8:30 am – 10:00 am USPTO: The Meat Inside the WIPO Standard ST.26 Nutshell; The Details of Sequence Listings in Patent Applications.Susan C. WolskiPCT Special Programs Examiner, USPTOWIPO Standard ST.26 is a revision of, and will replace, current WIPO Standard ST.25 for the presentation of sequence listings in patent applications. This workshop will take a more in-depth look at each of the components of the standard - the main body and its seven annexes. The specifics of the sequence listing data structure will be discussed, including the controlled vocabulary consisting of feature keys and qualifiers and their location descriptors and operators. Finally, some specific examples from the Annex VI Guidance Document will be reviewed to illustrate the manner of representation of different types of sequences, such as those containing D amino acids, nucleic acid analogues, branched portions of sequences, and variant sequences.

10:15 am – 11:15 am USPTO: The Patent Examination Process Including Different Approaches to Searching at the USPTO.Jackie Cheng, Supervisory Patent Examiner (biomedical), USPTOSue Liu, Supervisory Patent Examiner (biotechnology), USPTOLearn a bit about the patent examination process at the USPTO. In this presentation we will discuss what a USPTO examiners looks at when considering a patent application. We will also show different search approaches taken by examiners based on art area.

11:30 am – 12:30 pm Resources of InterestDr. David OsterburDirector of Entrepreneurial Ventures at the Harvard Medical School We will explore a variety of databases that are available through the National Center for Biotechnology Information. These include genomic and phenotype databases as well as gene expression databases. An introduction will also be given for a new role for librarians in the role of curators for an evidence-based medicine database.

C O N F E R E N C E W O R K S H O P S ( S E R R A N O A / B / C )


SAVE THESE DATES!

• PIUG Membership Directory (Members-Only Site)• Members-only access to Conference Proceedings

(Annual, Biotech, and Northeast Conferences)• Access to PIUG Salary Surveys• Discounts for World Patent Information,

Pharmaceutical Patent Analyst & JSTOR

• Quarterly e-Newsletter & Access to Archives• Enhanced functionality on PIUG Wiki• Ongoing professional training through

conferences and workshops• Access to PIUG LinkedIn group

ATTENDEE COMMENTS FROM A PREVIOUS PIUG CONFERENCE:“It is a great opportunity to talk with peers, get new ideas and be reminded of the essentials. I thoroughly enjoy the conference.”

“My first PIUG annual meeting and overall it was a great experience. As a first time attendee and speaker, I was initially intimidated, but so many of the “regulars”

were open and welcoming, it was actually less stressful than I expected. The first timer’s meeting was a blast, due in part to the great volunteers. I’m looking

forward to attending next year now that I know better what to expect.”

“Excellent…speakers from variety of industry and background”

“PIUG has certainly helped me a great deal in search

and analysis for my projects”

“Timely training on current TECHNIQUES and TOOLS”

Patent Information Users Group, Inc. • 40 E.Main Street, #1438 • Newark, DE 19711Phone: (302) 660-3275 • Email: [email protected] • www.piug.org

PIUG 2019ANNUAL CONFERENCEPreparing For The Future And The Unknown:New Technologies And Skills For The Patent Searcher

MAY 4 - 9The Westin Alexandria Alexandria, VA

PIUG 2019NORTHEAST CONFERENCESEPTEMBER 23 – 25APA Hotel, Iselin, NJ

KEY MEMBER BENEFITS

KEYNOTE SPEAKERLAURA A. PETER

Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the USPTO

Laura Peter is the Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the United States Patent and Trademark Office (USPTO).

In this role, she is responsible for all agency operations and managing approximately 13,000 employees.

Prior to joining the USPTO, Ms. Peter was the Deputy General Counsel of A10 Networks, where she oversaw daily legal matters related to commercial agreements,

litigation, and intellectual property (IP) portfolio development. In 2014, she helped shepherd the

company through its initial public offering.

Take a look at our new Hit Structure Reports!

www.bizint.com

• New in BizInt Smart Charts for Patents Version 5

• Supported from Classic STN, New STN and STNext

• Structure-oriented Index of Hit Structures with links to references

• Include hit structures and alignments in Summary Records

• Learn more at: bizint.com/hitstr

Come by our booth to talk about integrating sequence search results from GQ and STN.

We’re in Pioneer Squarein beautiful Seattle, WA

Vinca, one of the Viking 5 puppies born 8/18/2018

PIUG 2019 BIOTECHNOLOGY CONFERENCE - BizInt Solutions PIUG Biotech Meeting Book Final.pdf · PIUG...

Documents

Transcript of PIUG 2019 BIOTECHNOLOGY CONFERENCE - BizInt Solutions PIUG Biotech Meeting Book Final.pdf · PIUG...